Literature DB >> 12517903

Evaluation of a method for identification of Candida dubliniensis bloodstream isolates.

Banu Sancak1, John H Rex, Victor Paetznick, Enuo Chen, Jose Rodriguez.   

Abstract

To evaluate methods for differentiating Candida albicans and Candida dubliniensis, 772 putative C. albicans bloodstream isolates were tested for growth at 37 and 42 degrees C. Isolates showing no growth at 42 degrees C, abundant chlamydospore production, and the sugar assimilation pattern of the type strain were confirmed by DNA-based procedures to be C. dubliniensis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12517903      PMCID： PMC149562          DOI： 10.1128/JCM.41.1.489-491.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; H Goossens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

Review 2.  Candidiasis: the emergence of a novel species, Candida dubliniensis.

Authors:  D C Coleman; D J Sullivan; D E Bennett; G P Moran; H J Barry; D B Shanley
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

3.  Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors:  S Scherer; D A Stevens
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Evaluation of phenotypic markers for selection and identification of Candida dubliniensis.

Authors:  K Tintelnot; G Haase; M Seibold; F Bergmann; M Staemmler; T Franz; D Naumann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Molecular characterization by PCR-fingerprinting of Candida dubliniensis strains isolated from two HIV-positive patients in Spain.

Authors:  T M Diaz-Guerra; E Mellado; M Cuenca Estrella; F Laguna; J L Rodriguez-Tudela
Journal:  Diagn Microbiol Infect Dis       Date:  1999-10       Impact factor: 2.803

6.  Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.

Authors:  D Sullivan; K Haynes; J Bille; P Boerlin; L Rodero; S Lloyd; M Henman; D Coleman
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients.

Authors:  D Coleman; D Sullivan; B Harrington; K Haynes; M Henman; D Shanley; D Bennett; G Moran; C McCreary; L O'Neill
Journal:  Oral Dis       Date:  1997-05       Impact factor: 3.511

8.  Rapid identification of Candida dubliniensis using a species-specific molecular beacon.

Authors:  S Park; M Wong; S A Marras; E W Cross; T E Kiehn; V Chaturvedi; S Tyagi; D S Perlin
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Rapid identification of Candida dubliniensis with commercial yeast identification systems.

Authors:  D H Pincus; D C Coleman; W R Pruitt; A A Padhye; I F Salkin; M Geimer; A Bassel; D J Sullivan; M Clarke; V Hearn
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

10.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777
View more
  8 in total

1.  Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.

Authors:  Maria Eugenia Bosco-Borgeat; Constanza Giselle Taverna; Susana Cordoba; Maria Guillermina Isla; Omar Alejandro Murisengo; Wanda Szusz; Walter Vivot; Graciela Davel
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

2.  Discrimination between Candida albicans and Candida dubliniensis isolated from HIV-positive patients by using commercial method in comparison with PCR assay.

Authors:  H Bujdáková; S Melkusová; I Soji; M Mokrás; Y Mikami
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

4.  Use of a commercial reagent leads to reduced germ tube production by Candida dubliniensis.

Authors:  Leigh E Davis; Christine E Shields; William G Merz
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

5.  Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

6.  Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods.

Authors:  María Inés Alvarez; Blanca Lynne Suárez; Luz Dary Caicedo
Journal:  Mycopathologia       Date:  2008-07-12       Impact factor: 2.574

7.  Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.

Authors:  Zia U Khan; Suhail Ahmad; Eiman Mokaddas; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.